Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pattern-recognition receptors (PRRs) and scavenger receptors (SRs) are diverse groups of proteins primarily expressed on antigen-presenting cells (APCs), such as dendritic cells and macrophages, where they serve as the primary sensors of the innate immune system (Kumar et al., 2011) [1]. PRRs, including Toll-like receptors (TLRs) and C-type lectin receptors (CLRs), identify conserved molecular structures known as pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) (Janeway & Medzhitov, 2002) [5]. Scavenger receptors facilitate the clearance of altered self-molecules, such as oxidized low-density lipoproteins, and play a critical role in phagocytosis and lipid metabolism (Zani et al., 2015) [2]. Upon ligand binding, these receptors initiate signaling pathways that lead to the maturation of APCs, the secretion of pro-inflammatory cytokines, and the subsequent activation of the adaptive immune system (Banchereau et al., 2000) [3]. In clinical practice, these receptors are targeted by agonists like Imiquimod and CpG oligonucleotides to enhance vaccine efficacy and anti-tumor immunity (Kaczanowska et al., 2013) [4]. Conversely, inhibiting these pathways is a strategy for treating chronic inflammatory conditions and autoimmune diseases where overactive innate signaling contributes to tissue damage (Zani et al., 2015) [2].
Agonism of specific pattern-recognition receptors to stimulate innate and adaptive immunity; Antagonism of scavenger or pattern-recognition receptors to suppress pathological inflammation or lipid accumulation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern-recognition receptors and scavenger receptors on antigen-presenting cells (PRRs and SRs on APCs).